An innovative interventional radiology treatment has been found to offer chronic migraine sufferers sustained relief of their headaches, according to research being presented at the Society of Interventional Radiology’s Annual Scientific Meeting (28 February–5 Atlanta, USA).
According to research presented at the Society of Interventional Radiology’s (SIR’s) annual scientific meeting, clinicians were able to use prostate artery embolization to improve patient symptoms, regardless of the size of benign prostatic hyperplasia before the treatment, researchers found in a retrospective study.
Penumbra has announced that its newest vascular embolization device, POD, will debut at the Society of Interventional Radiology’s annual scientific meetingin 2015 in Atlanta, USA.
Researchers at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust are investigating whether ultrasound therapy can relieve pain in patients whose cancers have spread to the bone.
Analysis of a 285-patient subgroup treated with ThermoDox plus radiofrequency ablation shows a statistically significant 59% improvement in overall survival when compared to patients who were treated with optimised radiofrequency ablation alone.
Atlanta will play host to the launch of a unique new resource to support families affected by primary liver cancer. Medikidz Explain Primary Liver Cancer will be introduced at this year’s Society of Interventional Radiology Annual Scientific Meeting (28 February–5 March) and the Association of Radiologic and Imaging Nursing Spring Conference at the Georgia World Congress Center in Atlanta (1–2 March).
Early data from a multicentre, single-arm study that set out to evaluate the safety and effectiveness of a novel approach to inferior vena cava filtration using the VenaTech convertible filter (B Braun Interventional Systems) suggest that the use of this device yields favourable results.
ArtVentive Medical has announced the first use of its Endoluminal Occlusion System (EOS) in the USA at The Johns Hopkins Hospital in Baltimore, where Kelvin Hong and Anobel Tamrazi performed a splenic artery occlusion using the device.
At the Leipzig Interventional Course (LINC, 27–30 January, Leipzig, Germany), Michael Lichtenberg, chief of the Vascular Center Klinikum Arnsberg, Arnsberg, Germany, presented information about a new balloon dilatation catheter that allows a targeted injection of fluids during percutaneous transluminal angioplasty.
ClearFlow is currently exhibiting its PleuraFlow Active Clearance Technology system at the 34th annual Association of Physician Assistants in Cardiovascular Surgery (APACVS) meeting (1–4 March, Las Vegas, USA). PleuraFlow will also be displayed at the Maquet Medical Systems USA booth until 4 March. Maquet is the exclusive distributor of ClearFlow’s PleuraFlow system in the USA.
Cardinal Health announced on 2 March 2015 plans to acquire Johnson & Johnson’s Cordis business, a global manufacturer of cardiology and endovascular devices, for US$1.944 billion in cash, or approximately US$1.594 billion, net of the present value of tax benefits.
Gore reports that more than 2,500 patients have been enrolled in the Gore global registry for endovascular aortic treatment (GREAT). The registry is part of Gore’s dedication to post-market surveillance and monitoring long-term device performance in an effort to improve clinical practice and patient outcomes.
Researchers from CBSET have defined the optimal tissue debulking protocol for treating in-stent restenosis with Boston Scientific’s Jetstream Navitus atherectomy device. The findings were disclosed at the CRT 2015 annual scientific meeting (21–24 February) in Washington, DC, USA.
Biotronik has announced the presentation of promising data from the iliac arm of the BIOFLEX-I clinical trial at the Cardiovascular Research Technologies conference (21–24 February, Washington, DC, USA).
The US Food and Drug Administration (FDA) has approved Medtronic’s VenaSeal closure system to permanently treat varicose veins of the legs by sealing the affected superficial veins using an adhesive agent.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos